New Patents, Products, U.S. Marketing Mission Top Spring Agenda for International Drug and Explosive Detection Firm IDenta
JERUSALEM, Apr 10, 2007 (MARKET WIRE via COMTEX) -- IDenta Corp. (PINKSHEETS: IDTA) released a memorandum today detailing a number of significant activities the company will be undertaking in the coming months. The memo lists activities with the government of France, a U.S. visit by IDenta's CEO along with its Chief Scientist in early May, the development of a drug detector for morphine, the completion of testing for two new drug detectors, and applications for two new U.S. patents.
"It is hard to prioritize the value of these business activities, but do I feel that this mission to the U.S. may be our most important in a long time," said Yaacov Shoham, IDTA CEO. "Our marketing channels in the U.S. are beginning to report sales of drug detectors, as well as a growing interest in our IDenta Alert explosive detectors. We have scheduled high-level meetings in each of the cities we are visiting, and expect to make some very important announcements following this trip."
Significant company activities for the next three months include:
1. United States Marketing Mission -- the current schedule includes appointments with company representatives and law enforcement agencies in Orlando, Atlanta, Los Angles and New York.
2. Canada -- A visit to Toronto to finalize an agreement for product sales and representation.
3. GHB (a.k.a. date rape drugs) detection kits will soon be in production. The company believes there may be a significant consumer market for this detector because of the easy and inexpensive ability to detect the presence of illegal substances in substances such as alcoholic drinks served in bars and night clubs.
The Ketamine drug detector will also soon be in production.
4. IDenta is expecting to receive patents for several new products including the GHB kit (drug testing kit) and for TATP (explosive identifiers). Company testing of the TATP kit indicates it may be the most advanced, reliable explosive detector kit currently on the market.
5. The French Interior Minister has asked IDenta to develop a new drug detector for morphine.
6. The Marseille Laboratory in France is currently testing IDenta Alert explosive identifiers against other competing products. Indications from the company's representatives in France, IBTEC, indicate that the final report will be very positive.
Any publication or law enforcement agency interested in speaking directly with Mr. Shoham while he is in the U.S. may call 800-316-9437 or email him at fpi@drugsdetector.com.
A teleconference for the press and the investment community has tentatively been scheduled for May 1st at 9:30 a.m. eastern daylight time.
If anyone knows how to go about getting the info to be part of the teleconference, please let me know.
Regards,
Mike
